financetom
Business
financetom
/
Business
/
News Corp. Fiscal Q4 Earnings, Revenue Rise; Options for Foxtel Group on Table
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
News Corp. Fiscal Q4 Earnings, Revenue Rise; Options for Foxtel Group on Table
Aug 8, 2024 2:01 PM

04:32 PM EDT, 08/08/2024 (MT Newswires) -- News Corp. ( NWSA ) reported fiscal Q4 adjusted earnings Thursday of $0.17 per share, up from $0.14 a year earlier.

Analysts surveyed by Capital IQ expected $0.16.

Revenue for the quarter ended June 30 was $2.58 billion, up from $2.43 billion a year ago.

Analysts polled by Capital IQ expected $2.50 billion.

Meanwhile, the company declared a semi-annual cash dividend of $0.10 per Class A and Class B stock, payable Oct. 9 to shareholders of record on Sept. 11.

News Corp. ( NWSA ) also said it was assessing strategic and financial options for the Foxtel Group after receiving third-party interest in the business.

Price: 27.99, Change: +0.23, Percent Change: +0.83

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Blackstone Insider Sold Shares Worth $17,561,066, According to a Recent SEC Filing
Blackstone Insider Sold Shares Worth $17,561,066, According to a Recent SEC Filing
Oct 4, 2024
05:12 PM EDT, 10/03/2024 (MT Newswires) -- Joseph Baratta, Director, on October 01, 2024, sold 116,448 shares in Blackstone (BX) for $17,561,066. Following the Form 4 filing with the SEC, Baratta has control over a total of 799,749 shares of the company, with 799,749 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1393818/000095017024112492/xslF345X05/ownership.xml ...
Summit Therapeutics Completes Enrollment in Phase 3 Lung Cancer Drug Study
Summit Therapeutics Completes Enrollment in Phase 3 Lung Cancer Drug Study
Oct 4, 2024
04:39 PM EDT, 10/03/2024 (MT Newswires) -- Summit Therapeutics ( SMMT ) said late Thursday it has completed enrollment in its late-stage HARMONi clinical trial from sites in North America, Europe, and China, with topline data expected in mid-2025. The study is evaluating ivonescimab plus platinum-doublet chemotherapy against placebo plus platinum-doublet chemotherapy with epidermal growth factor receptor-mutated, locally advanced or...
Upstart Holdings Insider Sold Shares Worth $1,419,673, According to a Recent SEC Filing
Upstart Holdings Insider Sold Shares Worth $1,419,673, According to a Recent SEC Filing
Oct 4, 2024
04:33 PM EDT, 10/03/2024 (MT Newswires) -- Paul Gu, Director, Chief Technology Offier, on October 01, 2024, sold 36,200 shares in Upstart Holdings ( UPST ) for $1,419,673. Following the Form 4 filing with the SEC, Gu has control over a total of 878,565 shares of the company, with 878,565 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1647639/000162828024042156/xslF345X05/wk-form4_1727987268.xml Price: 38.87, Change: -0.07,...
PennyMac Financial Services, PennyMac Mortgage Investment Trust Announce Executive Changes
PennyMac Financial Services, PennyMac Mortgage Investment Trust Announce Executive Changes
Oct 4, 2024
05:06 PM EDT, 10/03/2024 (MT Newswires) -- PennyMac Financial Services ( PFSI ) said Thursday that William Chang is stepping down as senior managing director and chief capital markets officer to pursue other interests in the mortgage banking industry. Chang is also stepping down as senior managing director and chief investment officer of PennyMac Mortgage Investment Trust ( PMT )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved